Brokerages Anticipate HMS Holdings Corp (NASDAQ:HMSY) Will Announce Earnings of $0.26 Per Share

Equities analysts predict that HMS Holdings Corp (NASDAQ:HMSY) will announce earnings per share (EPS) of $0.26 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for HMS’s earnings, with estimates ranging from $0.22 to $0.29. HMS reported earnings of $0.25 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 4%. The firm is scheduled to issue its next quarterly earnings report before the market opens on Friday, August 2nd.

On average, analysts expect that HMS will report full year earnings of $1.17 per share for the current financial year, with EPS estimates ranging from $1.05 to $1.23. For the next fiscal year, analysts anticipate that the firm will report earnings of $1.28 per share, with EPS estimates ranging from $1.22 to $1.38. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for HMS.

HMS (NASDAQ:HMSY) last posted its earnings results on Friday, May 3rd. The business services provider reported $0.28 EPS for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.16. HMS had a return on equity of 14.02% and a net margin of 11.28%. The business had revenue of $148.00 million for the quarter, compared to analysts’ expectations of $144.13 million. During the same quarter in the previous year, the firm earned $0.22 earnings per share. The business’s revenue was up 4.7% compared to the same quarter last year.

A number of analysts have recently commented on the company. BidaskClub upgraded Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, July 4th. Cantor Fitzgerald cut HMS from an “overweight” rating to a “neutral” rating and set a $29.40 target price on the stock. in a research report on Wednesday, April 17th. Guggenheim started coverage on Patterson Companies in a research report on Wednesday, April 17th. They issued a “neutral” rating and a $23.00 price target on the stock. Credit Suisse Group started coverage on LTC Properties in a research report on Wednesday, July 10th. They issued an “underperform” rating and a $19.00 price target on the stock. Finally, Chardan Capital upgraded HMS from a “neutral” rating to a “buy” rating and boosted their price target for the company from $37.00 to $41.00 in a research report on Monday, July 1st. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. HMS presently has a consensus rating of “Buy” and an average target price of $33.57.

Shares of HMSY traded down $0.54 during midday trading on Monday, reaching $33.07. 297,614 shares of the stock were exchanged, compared to its average volume of 550,690. The firm has a 50-day simple moving average of $31.99. The company has a debt-to-equity ratio of 0.34, a current ratio of 5.34 and a quick ratio of 5.34. HMS has a twelve month low of $23.36 and a twelve month high of $38.15. The stock has a market cap of $2.93 billion, a P/E ratio of 39.37, a price-to-earnings-growth ratio of 3.05 and a beta of 1.41.

In other HMS news, Chairman William C. Lucia sold 22,978 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $31.79, for a total transaction of $730,470.62. Following the transaction, the chairman now owns 143,332 shares in the company, valued at approximately $4,556,524.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO William C. Lucia sold 1,700 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $31.62, for a total value of $53,754.00. Following the transaction, the chief executive officer now owns 143,332 shares in the company, valued at approximately $4,532,157.84. The disclosure for this sale can be found here. Insiders sold a total of 172,354 shares of company stock worth $5,347,710 in the last 90 days. 2.87% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HMSY. FDx Advisors Inc. lifted its stake in HMS by 2.7% in the 2nd quarter. FDx Advisors Inc. now owns 11,935 shares of the business services provider’s stock valued at $387,000 after buying an additional 313 shares in the last quarter. Navellier & Associates Inc boosted its position in shares of HMS by 26.8% during the 2nd quarter. Navellier & Associates Inc now owns 13,592 shares of the business services provider’s stock valued at $440,000 after acquiring an additional 2,870 shares in the last quarter. Fox Run Management L.L.C. acquired a new stake in shares of HMS during the 2nd quarter valued at about $211,000. Oregon Public Employees Retirement Fund boosted its position in shares of HMS by 4.6% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 33,997 shares of the business services provider’s stock valued at $1,101,000 after acquiring an additional 1,500 shares in the last quarter. Finally, OLD National Bancorp IN acquired a new stake in shares of HMS during the 2nd quarter valued at about $352,000. Institutional investors own 95.51% of the company’s stock.

About HMS

HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.

See Also: Bar Chart

Get a free copy of the Zacks research report on HMS (HMSY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.